MedPath

Clinical Evaluation of Tagara churna with Gokshuradi kwatha in Vyana bala vaishamya (Essential Hypertension Stage -1)

Phase 2
Not yet recruiting
Conditions
Essential (primary) hypertension. Ayurveda Condition: VYANAVATAKOPAH,
Registration Number
CTRI/2022/08/045025
Lead Sponsor
Uttarakhand Ayurveda University
Brief Summary

The trial will be conducted as a part of  Phd thesis.

A regime of Tagar churna 500mg bd and Gokshuradi kwatha 40ml bd will be given to one group while the other group will be prescribed Telmisartan 40mg od

Duration of the drug  trial will be 90 days

Each group will have 50 patients who will be selected randomly

The trial with the above said sample size will be completed within 2 years (24months)

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Newly diagnosed patients of essential hypertension stage 1 without any complication.
  • Old cases of essential hypertension stage 1 without complications who have discontinued the antihypertensive medicine for at least 30 days 3.
  • Age between 25 to 65 years.
  • Blood pressure measurement in the OPD (7 consecutive days) Systolic blood pressure- 140-159 mmHg Diastolic blood pressure- 90-99 mmHg.
Exclusion Criteria
  • Secondary hypertension 2.
  • Blood pressure measurement in the OPD Systolic blood pressure- >159 mmHg Diastolic blood pressure- >99 mmHg 3.
  • Any other coexisting serious medical & surgical illness.
  • Patients with complication of Hypertension.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. ShirorujaAssessment will be done at an interval of 15 days starting from the registration i.e. | 1st Assessment at Day 15 | 2nd Assessment at Day 30 | 3rd Assessment at Day 45 | 4th Assessment at Day 60 | 5th Assessment at Day 75 | 6th Assessment at Day 90
2. HriddravaAssessment will be done at an interval of 15 days starting from the registration i.e. | 1st Assessment at Day 15 | 2nd Assessment at Day 30 | 3rd Assessment at Day 45 | 4th Assessment at Day 60 | 5th Assessment at Day 75 | 6th Assessment at Day 90
3. KlamaAssessment will be done at an interval of 15 days starting from the registration i.e. | 1st Assessment at Day 15 | 2nd Assessment at Day 30 | 3rd Assessment at Day 45 | 4th Assessment at Day 60 | 5th Assessment at Day 75 | 6th Assessment at Day 90
4. BhramaAssessment will be done at an interval of 15 days starting from the registration i.e. | 1st Assessment at Day 15 | 2nd Assessment at Day 30 | 3rd Assessment at Day 45 | 4th Assessment at Day 60 | 5th Assessment at Day 75 | 6th Assessment at Day 90
5. AkshiragaAssessment will be done at an interval of 15 days starting from the registration i.e. | 1st Assessment at Day 15 | 2nd Assessment at Day 30 | 3rd Assessment at Day 45 | 4th Assessment at Day 60 | 5th Assessment at Day 75 | 6th Assessment at Day 90
6. KrodhaprachuryaAssessment will be done at an interval of 15 days starting from the registration i.e. | 1st Assessment at Day 15 | 2nd Assessment at Day 30 | 3rd Assessment at Day 45 | 4th Assessment at Day 60 | 5th Assessment at Day 75 | 6th Assessment at Day 90
7. AlpanidraAssessment will be done at an interval of 15 days starting from the registration i.e. | 1st Assessment at Day 15 | 2nd Assessment at Day 30 | 3rd Assessment at Day 45 | 4th Assessment at Day 60 | 5th Assessment at Day 75 | 6th Assessment at Day 90
Secondary Outcome Measures
NameTimeMethod
1. Systolic BP2. Diastolic BP

Trial Locations

Locations (1)

Faculty of Ayurveda Hospital

🇮🇳

Dehradun, UTTARANCHAL, India

Faculty of Ayurveda Hospital
🇮🇳Dehradun, UTTARANCHAL, India
Dr Jaya Saklani Kala
Principal investigator
9927249201
jk1ayush@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.